メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
医学部腫瘍センター
医学部
医学部クラスター部門
概要
フィンガープリント
ネットワーク
プロファイル
(9)
研究成果
(661)
フィンガープリント
医学部腫瘍センターが活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Endoscopic Submucosal Dissection
100%
Neoplasm
58%
Surgery
53%
Stomach Cancer
53%
Esophageal Cancer
47%
Esophagectomy
38%
Endoscopic Surgery
34%
Overall Survival
26%
Malignant Neoplasm
26%
Adverse Event
24%
Esophageal Squamous Cell Carcinoma
22%
Endoscopic Mucosal Resection
19%
Recurrent Disease
19%
Nivolumab
18%
Endoscopy
18%
Epithelioma
16%
Gastrectomy
16%
Disease
16%
Bleeding
16%
Non Small Cell Lung Cancer
15%
Lung Cancer
15%
Adenocarcinoma
14%
Diagnosis
12%
Odds Ratio
12%
Lymph Node Metastasis
12%
Chemoradiotherapy
12%
Metastatic Carcinoma
12%
Computer Assisted Tomography
11%
Sentinel Node
11%
Randomized Controlled Trial
11%
COVID-19
10%
Duodenum Tumor
10%
Meta-Analysis
10%
Cisplatin
10%
Retrospective Study
10%
Carcinoma
10%
Immune Checkpoint Inhibitor
9%
Retroperitoneal Lymph Node Dissection
9%
Lymph Node
8%
Cancer Cell
8%
Biological Marker
8%
Systematic Review
8%
Clinical Trial
7%
Narrow Band Imaging
7%
Colorectal Cancer
7%
Colorectal Tumor
7%
Epidermal Growth Factor Receptor
7%
Arm
7%
Multivariate Analysis
7%
Biopsy
7%
Placebo
7%
Lung Adenocarcinoma
6%
Colon
6%
Docetaxel
6%
Progression Free Survival
6%
Gastroesophageal Junction
6%
Radiation Therapy
6%
Postoperative Complication
6%
Duodenum
6%
Fluorouracil
6%
Adenoma
6%
Neoadjuvant Chemotherapy
6%
Squamous Cell Carcinoma
6%
Image Enhanced Endoscopy
5%
Sentinel-Node Mapping
5%
Esophagus
5%
Survival Rate
5%
Hazard Ratio
5%
Prognostic Factor
5%
Ulcer
5%
Anastomosis Leakage
5%
Esophagus Carcinoma
5%
Mucosa
5%
Pancreas Cancer
5%
Thoracic Duct
5%
Patient with Ulcerative Colitis
5%
Blood Stasis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Stomach Cancer
40%
Chemotherapy
32%
Esophagus Cancer
22%
Neoplasm
22%
Overall Survival
21%
Malignant Neoplasm
20%
Non Small Cell Lung Cancer
18%
Disease
15%
Lung Cancer
15%
Adverse Event
13%
Epidermal Growth Factor Receptor
12%
Pancreas Cancer
12%
Cisplatin
10%
Cohort Study
8%
Esophageal Squamous Cell Carcinoma
8%
Chemoradiation Therapy
8%
Helicobacter Pylori
8%
Progression Free Survival
8%
Symptom
8%
Nivolumab
7%
Fluorouracil
7%
Recurrent Disease
7%
Phase II Trials
7%
Placebo
7%
Irinotecan
6%
Coronavirinae
6%
Prospective Cohort Study
6%
Clinical Trial
5%
Infection
5%
Gemcitabine
5%
Combination Therapy
5%
Osimertinib
5%
Anticarcinogen
5%
Pharmacokinetics
5%
Sulfotransferase
5%
Inflammation
5%
Keyphrases
Endoscopic Submucosal Dissection
35%
Esophageal Cancer
16%
Confidence Interval
14%
Japan
12%
Chemotherapy
11%
Endoscopic Resection
10%
Overall Survival
10%
Gastric Cancer
10%
Nivolumab
9%
Superficial Duodenal Epithelial Tumor
8%
Early Gastric Cancer
8%
Meta-analysis
8%
Non-small Cell Lung Cancer (NSCLC)
7%
Odds Ratio
7%
Tumor
7%
Endoscopic mucosal Resection
7%
Japanese Patients
6%
Mucosal Defects
6%
COVID-19
6%
Esophageal Squamous Cell Carcinoma
6%
Phase II Trial
6%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
5%
Phase II Study
5%
En Bloc Resection
5%
Immune Checkpoint Inhibitors
5%
Advanced Gastric Cancer
5%
Long COVID
5%
Non-small Cell Lung Cancer Patients
5%
Systematic Meta-analysis
5%
Duodenal Endoscopic Submucosal Dissection
5%
Adverse Events
5%
Gastric Endoscopic Submucosal Dissection
5%
Multicenter Retrospective Study
5%
Retrospective Analysis
5%
Red Dichromatic Imaging
5%
Post-esophagectomy
5%